Patients co-infected with hepatitis C virus (HCV) and human immunodeficiency virus recover genotype cross-reactive neutralising antibodies to HCV during antiretroviral therapy

Patients co-infected with hepatitis C virus (HCV) and human immunodeficiency virus recover genotype cross-reactive neutralising antibodies to HCV during antiretroviral therapy

When severely immunodeficient HIV/HCV co-infected patients are treated with antiretroviral therapy, it is important to know whether HCV-specific antibody responses recover and whether antibody profiles predict the occurrence of HCV-associated immune restoration disease (IRD). In 50 HIV/HCV co-infect...

Full description

Bibliographic Details
Main Authors: Lee, S., Saraswati, H., Yunihastuti, E., Gani, R., Price, Patricia
Format: Journal Article
Published: Academic Press 2014
Subjects:
Genotype cross-reactive neutralising antibody
Antiretroviral therapy
HIV
HCV
Online Access:http://hdl.handle.net/20.500.11937/21202

Internet

http://hdl.handle.net/20.500.11937/21202

Similar Items